Skip to main content

Trazodone Hydrochloride

NDC 68071-2959 · NuCare Pharmaceuticals,Inc.

Generic nameTrazodone Hydrochloride
Dosage formTABLET
RouteORAL
Active ingredient(s)TRAZODONE HYDROCHLORIDE
Strength100 mg/1
Pharmacologic classSerotonin Reuptake Inhibitor [EPC]
Marketing categoryANDA

Packages

68071-2959-3 — 30 TABLET in 1 BOTTLE (68071-2959-3)

68071-2959-6 — 60 TABLET in 1 BOTTLE (68071-2959-6)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60687-954 — Trazodone Hydrochloride, 60760-806 — Trazodone Hydrochloride, 64980-672 — trazodone hydrochloride, 64980-673 — trazodone hydrochloride, 64980-674 — trazodone hydrochloride, 64980-675 — trazodone hydrochloride, 67046-1506 — Trazodone Hydrochloride, 67046-1540 — Trazodone Hydrochloride, 67046-1662 — Trazodone Hydrochloride, 67046-1684 — Trazodone Hydrochloride, 68071-2996 — Trazodone Hydrochloride, 68071-4410 — Trazodone Hydrochloride, 68071-4761 — Trazodone Hydrochloride, 68071-4833 — Trazodone Hydrochloride, 68382-609 — Trazodone Hydrochloride, 68382-610 — Trazodone Hydrochloride, 68382-805 — Trazodone Hydrochloride, 68382-806 — Trazodone Hydrochloride, 68382-807 — Trazodone Hydrochloride, 68382-808 — Trazodone Hydrochloride, +129 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T43.211 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), T43.212 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, T43.213 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, T43.214 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, T43.215 — Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, T43.216 — Underdosing of selective serotonin and norepinephrine reuptake inhibitors